CHRO

$13.50+$0.90 (+7.14%)prev close

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Change$-34.50

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
CHROChannel Therapeutics Corporation	$1.35	+7.14%	$9M	—
APGNApexigen, Inc.	$0.39	+8.48%	$10M	—
BIORBiora Therapeutics, Inc.	$0.22	+0.00%	$994994	—
CRVOCervoMed Inc.	$2.93	-4.56%	$27M	—
CSCICOSCIENS Biopharma Inc.	$2.72	+0.00%	$9M	—
IMVIFIMV Inc.	$0.00	+0.00%	$23423	—
OBSVObsEva S.A.	$0.10	+0.00%	$11M	—

Source: Financial Modeling Prep · peers by sector/industry

No one on the platform currently holds CHRO.

Institutions holding (13F)

No tracked institution reports a position in CHRO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Execution date	Ratio
2025-07-02	1-for-10reverse

No one on the platform has traded CHRO yet.